Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on 재발 성 후두 신경 손상
Total 0 results
Nothing found
Sponsors and Collaborators
Sichuan Haisco Pharmaceutical Group Co., Ltd
Doterra Healing Hands Foundation
EMET Pharmaceuticals, LLC
CARITAS Rundum zu Hause betreut
Invicta Medical Inc.
Alessandra Palo
Aga Khan Foundation, Pakistan
Eastman Kodak Company
Saint Pierre Institute - Palavas les Flots
Irish Endocrine Society
Outpatient Endovascular and Interventional Society
Axon Neuroscience SE
Grünenthal Denmark ApS
Yancheng City NO.1 People's Hospital
Gregorio Covino
Erzurum Regional Training & Research Hospital
YASEMİN AYDIN KARTAL
Department of Anesthesiology, North Denmark Regional Hospital
Phramongkutklao College of Medicine and Hospital
CeRSM
View Full List
Medical Conditions
Active Cocaine Users
Etomidate Overdose of Undetermined Intent
Fibromyoma;Cervix
Chemotherapy-induced Febrile Neutropenia (FN)
Animal-assisted Intervention
Lip and Oral Cavity Cancer
Shoulder Arthropathy
Blood Sampling
Adult Myxopapillary Ependymoma
Canaloplasty
Corticobasal Degeneration
Retroperitoneal Disease
Joint Arthroplasty
Documented Silent Ischemia
MEK Inhibitor-Associated Serous Retinopathy
B-cell Acute Lymphoblastic Leukemia
Contingent Versus Noncontingent Incentives
Desquamative Interstitial Pneumonia
Refractory Malignant Skin Neoplasm
Cough Variant Asthma
View Full List
Drug Interventions
Ranitidine
Anti-PD1 antibody, nimotuzumab and capecitabine
Amantadine Sulfate
Test varnish
Enteral oxygen therapy
Lenalidomide
Carbetocin
LY2216684
MYL-1501D product using manufacture process VI
Leuprolide acetate 11.25 mg
Niraparib
Neridronate
Apatinib
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Systemic intravenous lidocaine infusion
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
Risperidone
Pacritinib
Betamethasone
Pregabalin
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in China
Contract Research Organizations in El Salvador
Contract Research Organizations in Gabon
Contract Research Organizations in Greece
Contract Research Organizations in Ireland
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kenya
Contract Research Organizations in Mexico
Contract Research Organizations in Singapore
Contract Research Organizations in South Korea
Contract Research Organizations in United States
Contract Research Organizations in Vietnam
CRO list by country
CROs in Gambia
SGS
All CROs in Gambia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe